MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
BIOGEN AND CAPSIGEN ANNOUNCE COLLABORATION TO DISCOVER AND DEVELOP NOVEL AAV CAPSIDS FOR TARGETED CNS AND NEUROMUSCULAR DISORDERS
Guest UserMay 10, 2021
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

LiberoThera Closes 535 Million JPY Financing to Develop GPCR-targeting Therapeutics

Guest UserMay 14, 2021
Next

Blacksmith Medicines launches with seed funding and a research collaboration with Lilly

Guest UserJanuary 8, 2021

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact